Sun Pharmaceutical Industries Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has submitted a quarterly confirmation certificate to the stock exchanges as required under SEBI Regulation 74(5). The certificate, dated 5 July 2025 and issued by the company's Registrar & Share Transfer Agent (MUFG Intime India Pvt. Ltd.), covers the quarter ended 30 June 2025. It confirms that all securities received from depository participants for dematerialisation during the quarter were properly verified, listed on the stock exchanges, and reflected in the register of members. The RTA also noted that no requests for rematerialisation were received during the period. This is a routine, mandatory compliance filing with no operational or financial activity involved.
This is a standard regulatory compliance submission and has no direct impact on the company's financials, operations, or shareholder value. Investors can view this as housekeeping paperwork confirming the smooth functioning of share dematerialisation processes.